3 Questions Attys Have About Direct-To-Patient Drug Sales
As the Trump administration looks to lower drug prices, it's homed in on several potential strategies that it says will help patients in the U.S. pay as little for their drugs...To view the full article, register now.
Already a subscriber? Click here to view full article